Market Overview

Injectable Drug Delivery Research - Global Market Outlook 2017-2026

Share:

Injectable Drug Delivery Research - Global Market Outlook 2017-2026

PR Newswire

DUBLIN, Aug. 29, 2018 /PRNewswire/ --

Research and Markets Logo. (PRNewsFoto/Research and Markets) (PRNewsfoto/Research and Markets)

The "Injectable Drug Delivery - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.

According to the Global Injectable Drug Delivery market is expected to grow from $404.14 billion in 2017 to reach $1199.89 billion by 2026 with a CAGR of 12.8%.

Increasing prevalence of chronic diseases, expansion in the biologics market and technological advances in the form of nanotechnologies are some of the factors propelling the market growth. However, growing injuries and the infections caused by needles is hampering the market growth.

Drug delivery is the method of administering a pharmaceutical compound into the body through different routes to achieve a therapeutic effect. Oral, injection-based, transdermal, and carrier-based are some of the types of drug delivery devices. Injectable drug delivery facilitates the rapid transport of a drug into the body by passing first-pass metabolism. It also helps in administering drugs in unconscious and comatose patients. It is used in conditions such as hormonal imbalance, cystic fibrosis, autoimmune diseases, pain, Wilson's disease, hemophilia, hepatitis C and ribose-5-phosphate isomerase deficiency.

Based on formulation packaging, Ampules segment has a significant growth in the market owing to its good barrier properties as compared to other types of packaging. In addition they offer better protection at a lesser cost, ease of transportation and low costs of manufacturing are the factors driving the market in this segment.

By Geography, North America was estimated to be the largest share for the market during the forecast period. The growth is attributed to the rising dominance of chronic diseases and the number of companies that are focused on collaboration and partnerships to ensure the availability of high-value products.

What our report offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends.
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements.

Key Topics Covered:

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.5 Research Sources

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Injectable Drug Delivery Market, By Type
5.1 Introduction
5.2 Formulations
5.2.1 Novel Drug Delivery Formulations
5.2.1.1 Microparticles
5.2.1.1.1 Microcapsules
5.2.1.1.2 Microspheres
5.2.1.2 Colloidal Dispersions
5.2.1.2.1 Polymeric/Mixed Micelles
5.2.1.2.2 Niosomes
5.2.1.2.3 Liposomes
5.2.1.2.4 Nanoparticles
5.2.1.2.4.1 Nanoemulsions
5.2.1.2.4.2 Solid-Lipid Nanoparticles
5.2.1.2.4.3 Nanosuspensions
5.2.2 Conventional Drug Delivery Formulations
5.2.2.1 Reconstituted/Lyophilized Formulations
5.2.2.2 Emulsions
5.2.2.3 Solutions
5.2.2.4 Suspensions
5.2.3 Long-Acting Injection Formulations
5.3 Devices
5.3.1 Conventional Injection Devices
5.3.1.1 Material
5.3.1.1.1 Plastic
5.3.1.1.2 Glass
5.3.1.2 Usability
5.3.1.2.1 Disposable Injection Devices
5.3.1.2.2 Reusable Injection Devices
5.3.1.3 Product
5.3.1.3.1 Prefilled Syringes
5.3.1.3.2 Fillable Syringes
5.3.2 Self-Injection Devices
5.3.2.1 Needle-Free Injectors
5.3.2.1.1 Technology
5.3.2.1.1.1 Spring-Based Needle-Free Injectors
5.3.2.1.1.2 Vibration-Based Needle-Free Injectors
5.3.2.1.1.3 Jet-Based Needle-Free Injectors
5.3.2.1.1.4 Laser-Powered Needle-Free Injectors
5.3.2.1.2 Product
5.3.2.1.2.1 Prefilled Needle-Free Injectors
5.3.2.1.2.2 Fillable Needle-Free Injectors
5.3.2.1.3 Usability
5.3.2.1.3.1 Disposable Needle-Free Injectors
5.3.2.1.3.2 Reusable Needle-Free Injectors
5.3.2.2 Autoinjectors
5.3.2.2.1 Design
5.3.2.2.1.1 Customized Autoinjectors
5.3.2.2.1.2 Standardized Autoinjectors
5.3.2.2.2 Technology
5.3.2.2.2.1 Manual Autoinjectors
5.3.2.2.2.2 Automated Autoinjectors
5.3.2.2.3 Product
5.3.2.2.3.1 Prefilled Autoinjectors
5.3.2.2.3.2 Fillable Autoinjectors
5.3.2.2.4 Usability
5.3.2.2.4.1 Disposable Autoinjectors
5.3.2.2.4.2 Reusable Autoinjectors
5.3.2.3 Pen Injectors
5.3.2.3.1 Design
5.3.2.3.1.1 Customized Pen Injectors
5.3.2.3.1.2 Standard Pen Injectors
5.3.2.3.2 Product
5.3.2.3.2.1 Dual-Chambered Pen Injectors
5.3.2.3.2.2 Single-Chambered Pen Injectors
5.3.2.3.3 Usability
5.3.2.3.3.1 Disposable Pen Injectors
5.3.2.3.3.2 Reusable Pen Injectors
5.3.2.4 Wearable Injectors
5.3.3 Integrated safety syringes
5.3.4 Patch injectors
5.3.5 Safety Syringes
5.3.6 Subcutaneous infusion devices
5.3.7 Other Devices

6 Global Injectable Drug Delivery Market, By Formulation Packaging
6.1 Introduction
6.2 Cartridges
6.3 Ampules
6.4 Bottles
6.5 Vials

7 Global Injectable Drug Delivery Market, By Usage Pattern
7.1 Introduction
7.2 Immunization
7.3 Curative Care
7.4 Other Usage Patterns

8 Global Injectable Drug Delivery Market, By Facility of Use
8.1 Introduction
8.2 Home Care Settings
8.3 Hospitals and Clinics
8.4 Other Facilities of Use

9 Global Injectable Drug Delivery Market, By Site of Administration
9.1 Introduction
9.2 Circulatory/Musculoskeletal System (Intravenous, Intracardiac, Intramuscular, and Intraperitoneal)
9.3 Skin (Intradermal and Subcutaneous)
9.4 Central Nervous System (Intracerebral and Intrathecal)
9.5 Organs (Intravitreal and Intra-Articular)

10 Global Injectable Drug Delivery Market, By Application
10.1 Introduction
10.2 Hormonal Disorders
10.2.1 Anemia
10.2.2 Antithrombotic/Thrombolytic Therapy
10.2.3 Growth Hormone Deficiency (GHD)
10.2.4 Diabetes
10.2.5 Osteoporosis
10.2.6 Reproductive Health Disease
10.3 Autoimmune Diseases
10.3.1 Multiple Sclerosis (MS)
10.3.2 Psoriasis
10.3.3 Rheumatoid Arthritis
10.3.4 Crohn's Disease
10.3.5 Other Autoimmune Diseases
10.4 Cancer
10.5 Orphan Diseases
10.6 Cardiovascular diseases
10.7 Neurology Addiction
10.8 Respiratory Diseases
10.9 Regenerative Medicine
10.10 Oncology
10.11 Other Therapeutic Applications
10.11.1 Aesthetic Treatment
10.11.2 Pain Management
10.11.3 Hemophilia
10.11.4 Hepatitis C
10.11.5 Allergies

11 Global Injectable Drug Delivery Market, By Distribution Channel
11.1 Introduction
11.2 Retail Pharmacy Stores
11.3 Hospitals
11.4 E-Commerce

12 Global Injectable Drug Delivery Market, By End User
12.1 Introduction
12.2 Ambulatory Care
12.3 Home Based
12.4 Clinics/Physician Offices
12.5 Other End Users

13 Global Injectable Drug Delivery Market, By Geography
13.1 Introduction
13.2 North America
13.3 Europe
13.4 Asia Pacific
13.5 South America
13.6 Middle East & Africa

14 Key Developments
14.1 Agreements, Partnerships, Collaborations and Joint Ventures
14.2 Acquisitions & Mergers
14.3 New Product Launch
14.4 Expansions
14.5 Other Key Strategies

15 Company Profiling
15.1 Baxter International, Inc.
15.2 ELI Lilly and Company
15.3 Terumo Corporation
15.4 Becton, Dickinson and Company
15.5 Pfizer, Inc.
15.6 Gerresheimer AG
15.7 Teva Pharmaceutical Industries Ltd.
15.8 Schott AG
15.9 Sandoz
15.1 Antares Pharma, Inc.,
15.11 Zogenix, Inc.
15.12 Scandinavian Health Limited
15.13 Terumo Medical Corp.,
15.14 Ypsomed Holding AG
15.15 Unilife Corporation,
15.16 Vetter Pharma-Fertigung GmbH & Co. KG.
15.17 Nova Nordisk A/S

For more information about this report visit https://www.researchandmarkets.com/research/8mqx22/injectable_drug?w=5

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/injectable-drug-delivery-research---global-market-outlook-2017-2026-300703998.html

SOURCE Research and Markets

View Comments and Join the Discussion!